Nasopharyngeal Swabs Market (Application: Influenza, COVID-19, Respiratory Syncytial Virus, Bordetella Pertussis Infection, MRSA [Methicillin-resistant Staphylococcus Aureus], and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
Nasopharyngeal Swabs Market – Scope of Report
TMR’s report on the global nasopharyngeal swabs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nasopharyngeal swabs market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nasopharyngeal swabs market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the nasopharyngeal swabs market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nasopharyngeal swabs market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nasopharyngeal swabs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nasopharyngeal swabs market.
The report delves into the competitive landscape of the global nasopharyngeal swabs market. Key players operating in the global nasopharyngeal swabs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nasopharyngeal swabs market profiled in this report.
Key Questions Answered in Global Nasopharyngeal Swabs Market Report
- What is the sales/revenue generated by nasopharyngeal swabs across all regions during the forecast period?
- What are the opportunities in the global nasopharyngeal swabs market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
The comprehensive report on the global nasopharyngeal swabs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global nasopharyngeal swabs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nasopharyngeal swabs market.
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Nasopharyngeal Swabs Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Nasopharyngeal Swabs Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
- 5. Key Insights
- 5.1. Key Industry Events
- 5.2. Technological Advancements
- 5.3. Epidemiology of Infectious Diseases, by Country/Region
- 5.4. COVID-19 Pandemic Impact on Industry
- 6. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Type, 2017-2031
- 6.3.1. Foam Tipped Swabs
- 6.3.2. Non-woven Swabs
- 6.3.3. Others
- 6.4. Market Attractiveness Analysis, by Type
- 7. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Influenza
- 7.3.2. COVID-19
- 7.3.3. Respiratory Syncytial Virus
- 7.3.4. Bordetella Pertussis Infection
- 7.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
- 7.3.6. Others
- 7.4. Market Attractiveness Analysis, by Application
- 8. Global Nasopharyngeal Swabs Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Clinics
- 8.3.3. Academia & Research Institutes
- 8.3.4. Others
- 8.4. Market Attractiveness Analysis, by End-user
- 9. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region, 2017-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
- 10. North America Nasopharyngeal Swabs Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Type, 2017-2031
- 10.2.1. Foam Tipped Swabs
- 10.2.2. Non-woven Swabs
- 10.2.3. Others
- 10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Influenza
- 10.3.2. COVID-19
- 10.3.3. Respiratory Syncytial Virus
- 10.3.4. Bordetella Pertussis Infection
- 10.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
- 10.3.6. Others
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Clinics
- 10.4.3. Academia & Research Institutes
- 10.4.4. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Type
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
- 11. Europe Nasopharyngeal Swabs Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Type, 2017-2031
- 11.2.1. Foam Tipped Swabs
- 11.2.2. Non-woven Swabs
- 11.2.3. Others
- 11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Influenza
- 11.3.2. COVID-19
- 11.3.3. Respiratory Syncytial Virus
- 11.3.4. Bordetella Pertussis Infection
- 11.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
- 11.3.6. Others
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Clinics
- 11.4.3. Academia & Research Institutes
- 11.4.4. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Type
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
- 12. Asia Pacific Nasopharyngeal Swabs Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Type, 2017-2031
- 12.2.1. Foam Tipped Swabs
- 12.2.2. Non-woven Swabs
- 12.2.3. Others
- 12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Influenza
- 12.3.2. COVID-19
- 12.3.3. Respiratory Syncytial Virus
- 12.3.4. Bordetella Pertussis Infection
- 12.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
- 12.3.6. Others
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Clinics
- 12.4.3. Academia & Research Institutes
- 12.4.4. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Type
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
- 13. Latin America Nasopharyngeal Swabs Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Type, 2017-2031
- 13.2.1. Foam Tipped Swabs
- 13.2.2. Non-woven Swabs
- 13.2.3. Others
- 13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Influenza
- 13.3.2. COVID-19
- 13.3.3. Respiratory Syncytial Virus
- 13.3.4. Bordetella Pertussis Infection
- 13.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
- 13.3.6. Others
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Clinics
- 13.4.3. Academia & Research Institutes
- 13.4.4. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Type
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
- 14. Middle East & Africa Nasopharyngeal Swabs Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Type, 2017-2031
- 14.2.1. Foam Tipped Swabs
- 14.2.2. Non-woven Swabs
- 14.2.3. Others
- 14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Influenza
- 14.3.2. COVID-19
- 14.3.3. Respiratory Syncytial Virus
- 14.3.4. Bordetella Pertussis Infection
- 14.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
- 14.3.6. Others
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Clinics
- 14.4.3. Academia & Research Institutes
- 14.4.4. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Type
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
- 15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2022
- 15.3. Company Profiles
- 15.3.1. Thermo Fisher Scientific, Inc.
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. Financial Overview
- 15.3.1.4. SWOT Analysis
- 15.3.1.5. Strategic Overview
- 15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company)
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. Financial Overview
- 15.3.2.4. SWOT Analysis
- 15.3.2.5. Strategic Overview
- 15.3.3. Medical Wire & Equipment (MWE)
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. Financial Overview
- 15.3.3.4. SWOT Analysis
- 15.3.3.5. Strategic Overview
- 15.3.4. Titan Biotech Ltd.
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. Financial Overview
- 15.3.4.4. SWOT Analysis
- 15.3.4.5. Strategic Overview
- 15.3.5. COPAN Diagnostics, Inc.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. Financial Overview
- 15.3.5.4. SWOT Analysis
- 15.3.5.5. Strategic Overview
- 15.3.6. Miraclean Technology Co., Ltd.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. Financial Overview
- 15.3.6.4. SWOT Analysis
- 15.3.6.5. Strategic Overview
- 15.3.7. Puritan Medical Products
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. Financial Overview
- 15.3.7.4. SWOT Analysis
- 15.3.7.5. Strategic Overview
- 15.3.8. YOCON Biology
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. Financial Overview
- 15.3.8.4. SWOT Analysis
- 15.3.8.5. Strategic Overview
- 15.3.9. Trinity Biotech
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. Financial Overview
- 15.3.9.4. SWOT Analysis
- 15.3.9.5. Strategic Overview
- 15.3.10. VIRCELL S.L.
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Product Portfolio
- 15.3.10.3. Financial Overview
- 15.3.10.4. SWOT Analysis
- 15.3.10.5. Strategic Overview
- 15.3.11. Quidel Corporation
- 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.11.2. Product Portfolio
- 15.3.11.3. Financial Overview
- 15.3.11.4. SWOT Analysis
- 15.3.11.5. Strategic Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook